Evolution of the psychiatric phenotype in the early stages of a Huntington's disease preclinical modelBaptiste Dayre, Katleen Pinchaud, Peter Vanhoutte, Sandrine Betuing
Retinal dysfunction in Huntington’s disease mouse models is characterized by an early photoreceptor degeneration and a late neuroinflammationJorge Navarro Calvo, Paula Martín-Climent, Fátima Cano-Cano et al.
Targeting the AMPK pathway as a treatment strategy for Huntington’s diseaseBalázs Kis, Varga Ágnes, Hühn Daniela et al.